Clinical Trial Update: Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae [Phase 4]

View source ↗

Summary

Phase 4 trial comparing piperacillin/tazobactam with carbapenems for non-bacteremic urinary tract infections due to ESBL-producing Enterobacteriaceae; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Carbapenems (carbapenems)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Universidad del Norte | Conditions: Urinary Tract Infections, Enterobacteriaceae Infections | Phase 4 | Status: SUSPENDED